[EN] BRIDGED RING COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF<br/>[FR] COMPOSÉS DE TYPE CYCLES À PONTS À TITRE D'INHIBITEURS DU VIRUS DE L'HÉPATITE C, COMPOSITIONS PHARMACEUTIQUES ET LEURS UTILISATIONS
申请人:SUNSHINE LAKE PHARMA CO LTD
公开号:WO2014131315A1
公开(公告)日:2014-09-04
Provided herein is a compound of formula (I) or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, which can be used for treating HCV infection or a HCV disorder. Also provided herein are a pharmaceutical composition comprising the compound and the use of the compound and the pharmaceutical composition thereof, which can also be used for treating HCV infection or a HCV disorder.
A Simple Procedure for Preparing Annulated<i>p</i>-Benzoquinones. Improved Synthesis of 1,4-Dihydro-1,4-methanonaphthalene-5,8-dione
作者:Alan P. Marchand、Sulejman Alihodzic、Rajesh Shukla
DOI:10.1080/00397919808005109
日期:1998.2
Abstract A simple and efficient two-step, one-pot synthesis of substituted 1,4-dihydro-1,4-methanonaphthalene-5,8-diones is reported. This synthesis, which utilizes readily available starting materials and inexpensive reagents, can be used to prepare 1a-1c in 70–90% overall yield. This procedure was extended successfully to prepare a more highly complex annulated p-benzoquinone i.e., 8.